(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
@ $5.29
Išleistas: 14 vas. 2024 @ 21:56
Grąža: -21.36%
Ankstesnis signalas: vas. 13 - 22:19
Ankstesnis signalas:
Grąža: 1.15 %
Live Chart Being Loaded With Signals
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States...
Stats | |
---|---|
Šios dienos apimtis | 79 222.00 |
Vidutinė apimtis | 180 790 |
Rinkos kapitalizacija | 54.03M |
EPS | $0 ( 2024-04-07 ) |
Kita pelno data | ( $0 ) 2024-06-27 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 4.89 |
ATR14 | $0.0100 (0.24%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-02-28 | Tarriff Scott | Sell | 2 119 | Common Stock |
2024-02-27 | Cahill Brian Joseph | Buy | 3 800 | Common Stock |
2024-02-27 | Cahill Brian Joseph | Sell | 1 589 | Common Stock |
2024-02-27 | Tarriff Scott | Buy | 12 950 | Common Stock |
2024-02-27 | Tarriff Scott | Sell | 3 154 | Common Stock |
INSIDER POWER |
---|
59.28 |
Last 99 transactions |
Buy: 818 589 | Sell: 362 958 |
Tūris Koreliacija
Eagle Pharmaceuticals Inc Koreliacija
10 Labiausiai teigiamai susiję koreliacijos | |
---|---|
RMRM | 0.965 |
SVAC | 0.963 |
PINC | 0.943 |
TLGT | 0.939 |
WMG | 0.936 |
TUEM | 0.926 |
PAIC | 0.924 |
JRJC | 0.923 |
IEP | 0.922 |
COLM | 0.918 |
10 Labiausiai neigiamai susiję koreliacijos | |
---|---|
AMRB | -0.956 |
NETE | -0.951 |
MORF | -0.949 |
AVDL | -0.931 |
WPRT | -0.928 |
RXDX | -0.927 |
NYMTN | -0.92 |
COKE | -0.919 |
FLMN | -0.919 |
KBWD | -0.917 |
Ar žinojote?
Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).
Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.
Eagle Pharmaceuticals Inc Koreliacija - Valiuta/Žaliavos
Eagle Pharmaceuticals Inc Finansinės ataskaitos
Annual | 2022 |
Pajamos: | $316.61M |
Bruto pelnas: | $221.67M (70.01 %) |
EPS: | $2.76 |
FY | 2022 |
Pajamos: | $316.61M |
Bruto pelnas: | $221.67M (70.01 %) |
EPS: | $2.76 |
FY | 2021 |
Pajamos: | $171.55M |
Bruto pelnas: | $129.37M (75.41 %) |
EPS: | $-0.0359 |
FY | 2020 |
Pajamos: | $187.80M |
Bruto pelnas: | $142.34M (75.79 %) |
EPS: | $0.890 |
Financial Reports:
No articles found.
Eagle Pharmaceuticals Inc
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and indolent B-cell non-Hodgkin's lymphoma. Its product candidates also include EP-4104, a dantrolene sodium to treat organophosphate exposure; PEMFEXY, a ready-to-use/dilute liquid form of pemetrexed for non-small cell lung cancer and mesothelioma; EA-114 (fulvestrant) for HR+/HER- breast cancer; and Vasopressin injection, which is indicated to enhance blood pressure in adults with vasodilatory shock. The company has license and collaboration agreements with Combioxin, SA for the development and commercialization rights to CAL02, an antitoxin agent for the treatment of severe pneumonia in combination with traditional antibacterial drugs; and AOP Orphan Pharmaceuticals GmbH for the commercial rights of Landiolol, a novel therapeutic product candidate for the short-term reduction of ventricular rate in patients with supraventricular tachycardia, including atrial fibrillation and atrial flutter. It has a strategic collaboration with Tyme Technologies, Inc. for the development of SM-88 to treat breast cancer (HR+/HER2-) and high-risk metastatic sarcomas. Eagle Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Woodcliff Lake, New Jersey.
Apie Signalai gyvai
Šiame puslapyje pateikti tiesioginiai signalai padeda nustatyti, kada PIRKTI ar PARDUOTI NA. Signalai vėluoja 1 minutę; kaip ir su visais rinkos signalais, taip ir su šiais, visuomet yra klaidų tikimybė.
Tiesioginiai prekybos signalai nėra apibrėžti, todėl getagraph.com neprisiima atsakomybės už jokius veiksmus, kurių buvo imtasi žinant šiuos signalus, kaip aprašyta Naudojimo sąlygose. Signalai yra pagrįsti įvairiais techninės analizės rodikliais.